🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06890806
Active, not recruiting Not applicable

Foot Core Stabilization Exercises Vs. Shockwave Therapy for Pain, Strength, and Function in Plantar Fasciitis

NCT06890806 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-03-01
Last updated
2025-03-24

Condition(s) studied

Plantar Fasciitis of Both Feet

Investigational drug(s) / intervention(s)

Foot Core Stabilization Exercise Group (FCSEG)Extracorporeal Shock Wave Therapy Group (ESWTG)

Foot Core Stabilization Exercise Group (FCSEG): Exercise Group (Foot Core Stabilization Exercises) Exercise Group will perform foot core stabilization exercises under the supervision of a physiotherapist, three times a week for five weeks. The exercises will include: Short foot exercise Towel curl exercise Big toe press exercise Toe splay exercise Calf raise to big toe press exercise Leg swings Backward tandem walking Each exercise will be performed in three sets of 15 repetitions.

Extracorporeal Shock Wave Therapy Group (ESWTG): Extracorporeal Shock Wave Therapy Group (ESWTG) One group will receive Extracorporeal Shock Wave Therapy (ESWT) once a week for five weeks. The ESWT sessions will be performed using the Gymna Shockmaster 500 device at a frequency of 15 Hz and a pressure of 3 bar, delivering a total of 1800 pulses per session.

Study summary

This study aims to evaluate the effectiveness and feasibility of two distinct approache extracorporeal shock wave therapy and foot core stabilization exercises in the treatment of plantar faciitis (PF) by comparing their impacts on pain, muscle strength, and functionality. The study seeks to better understand the role of innovative exercise protocols in addressing biomechanical imbalances and the contribution of ESWT to biological healing mechanisms. The anticipated results are expected to provide evidence-based treatment approaches that can enhance the quality of life in individuals with PF, guide clinical applications in physical medicine and rehabilitation, and strengthen the position of these treatment methods within the broader healthcare system. Moreover, the findings may benefit a larger patient population by improving the management of PF.

Eligibility

Sex
ALL
Min age
25 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 25 to 60 years who have been diagnosed with plantar fasciitis by a physician specializing in physical medicine and rehabilitation or an orthopedic specialist. * Heel pain localized to the medial calcaneal tubercle, persisting for three months or longer. * Pain that worsens with the first steps taken in the morning or after periods of rest. Exclusion Criteria: * Individuals who have undergone foot or ankle surgery. * Individuals with a history of chronic or active infection in the treatment area. * Individuals with Type 1 or Type 2 Diabetes Mellitus, systemic inflammatory arthritis, cancer, active tuberculosis, or a history of neurological or vascular diseases. * Individuals who have undergone conservative treatment including nonsteroidal anti-inflammatory drugs for 6 months with no significant improvement. * Patients with numbness or tingling in the lower extremity, with or without provocation, or those with undiagnosed pain. * Pregnancy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mudanya University Bursa Bursa

More Istanbul Medipol University Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06890806 on ClinicalTrials.gov ↗ ← All trials in Turkey